Clinical Challenge: Neonatal Jaundice
Neonatal jaundice affects a significant proportion of newborns and, if left untreated, can lead to serious complications. Hospitals need a reliable, measurable, and easy‑to‑use phototherapy solution that provides the right spectral output and irradiance at the infant’s skin.
Our Solution: BioLuxy
- Optimal wavelength range (450–465 nm) for bilirubin photo‑isomerization and breakdown.
- High irradiance to accelerate therapy: >45 μW/cm²/nm (high mode) and >22 μW/cm²/nm (low mode).
- Five irradiance levels to tailor treatment per patient.
- Uniform light distribution across a large effective area for maximum skin exposure.
- Integrated distance sensor and irradiance probe port for accurate dosing at the infant’s position.
- Two operation modes: Timer Mode and Distance Mode for protocol‑driven delivery.
- 4‑inch LCD touch screen for intuitive setup and real‑time monitoring.
- Red laser pointer to precisely center the infant within the irradiation field.
- Quiet, long‑life LEDs (up to 50,000 working hours) with thermal protection and visual alarms.
How It Works
BioLuxy PT‑20 uses high‑efficiency blue LEDs tuned to the optimal spectral band. The system measures distance and irradiance, allowing clinicians to deliver a consistent therapeutic dose to the infant’s skin while minimizing noise and heat.
Illustrative Figures
The following figures provide visual context for wavelength selection, irradiance behavior, and a typical clinical workflow.
Benefits
- Shorter treatment times and consistent dosing.
- Improved safety through distance sensing, thermal protection, and alarms.
- Easy, protocol‑driven operation with Timer and Distance modes.
- Lower total cost of ownership with long‑life LEDs and low noise operation.
